254 related articles for article (PubMed ID: 20976201)
21. Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes.
Voo KS; Fu T; Wang HY; Tellam J; Heslop HE; Brenner MK; Rooney CM; Wang RF
J Exp Med; 2004 Feb; 199(4):459-70. PubMed ID: 14769850
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
Ressing ME; Horst D; Griffin BD; Tellam J; Zuo J; Khanna R; Rowe M; Wiertz EJ
Semin Cancer Biol; 2008 Dec; 18(6):397-408. PubMed ID: 18977445
[TBL] [Abstract][Full Text] [Related]
23. The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II.
Quinn LL; Williams LR; White C; Forrest C; Zuo J; Rowe M
J Virol; 2016 Jan; 90(1):356-67. PubMed ID: 26468525
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells.
Albanese M; Tagawa T; Bouvet M; Maliqi L; Lutter D; Hoser J; Hastreiter M; Hayes M; Sugden B; Martin L; Moosmann A; Hammerschmidt W
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6467-E6475. PubMed ID: 27698133
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.
Levitskaya J; Sharipo A; Leonchiks A; Ciechanover A; Masucci MG
Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12616-21. PubMed ID: 9356498
[TBL] [Abstract][Full Text] [Related]
26. Avoiding proteasomal processing: the case of EBNA1.
Dantuma NP; Sharipo A; Masucci MG
Curr Top Microbiol Immunol; 2002; 269():23-36. PubMed ID: 12224511
[TBL] [Abstract][Full Text] [Related]
27. The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules trafficking on both the exocytic and endocytic pathways.
Zuo J; Quinn LL; Tamblyn J; Thomas WA; Feederle R; Delecluse HJ; Hislop AD; Rowe M
J Virol; 2011 Feb; 85(4):1604-14. PubMed ID: 21123379
[TBL] [Abstract][Full Text] [Related]
28. The nascent polypeptide-associated complex (NAC) controls translation initiation in cis by recruiting nucleolin to the encoding mRNA.
Zheng AJL; Thermou A; Daskalogianni C; Malbert-Colas L; Karakostis K; Le Sénéchal R; Trang Dinh V; Tovar Fernandez MC; Apcher S; Chen S; Blondel M; Fahraeus R
Nucleic Acids Res; 2022 Sep; 50(17):10110-10122. PubMed ID: 36107769
[TBL] [Abstract][Full Text] [Related]
29. Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1.
Tellam J; Connolly G; Green KJ; Miles JJ; Moss DJ; Burrows SR; Khanna R
J Exp Med; 2004 May; 199(10):1421-31. PubMed ID: 15148340
[TBL] [Abstract][Full Text] [Related]
30. A repetitive sequence of Epstein-Barr virus nuclear antigen 6 comprises overlapping T cell epitopes which induce HLA-DR-restricted CD4(+) T lymphocytes.
Rajnavölgyi E; Nagy N; Thuresson B; Dosztányi Z; Simon A; Simon I; Karr RW; Ernberg I; Klein E; Falk KI
Int Immunol; 2000 Mar; 12(3):281-93. PubMed ID: 10700463
[TBL] [Abstract][Full Text] [Related]
31. Influence of translation efficiency of homologous viral proteins on the endogenous presentation of CD8+ T cell epitopes.
Tellam J; Fogg MH; Rist M; Connolly G; Tscharke D; Webb N; Heslop L; Wang F; Khanna R
J Exp Med; 2007 Mar; 204(3):525-32. PubMed ID: 17312009
[TBL] [Abstract][Full Text] [Related]
32. The central repeat domain 1 of Kaposi's sarcoma-associated herpesvirus (KSHV) latency associated-nuclear antigen 1 (LANA1) prevents cis MHC class I peptide presentation.
Kwun HJ; da Silva SR; Qin H; Ferris RL; Tan R; Chang Y; Moore PS
Virology; 2011 Apr; 412(2):357-65. PubMed ID: 21324504
[TBL] [Abstract][Full Text] [Related]
33. The nested open reading frame in the Epstein-Barr virus nuclear antigen-1 mRNA encodes a protein capable of inhibiting antigen presentation in cis.
Ossevoort M; Zaldumbide A; te Velthuis AJ; Melchers M; Ressing ME; Wiertz EJ; Hoeben RC
Mol Immunol; 2007 Jul; 44(14):3588-96. PubMed ID: 17449101
[TBL] [Abstract][Full Text] [Related]
34. Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.
Khanna R; Burrows SR; Steigerwald-Mullen PM; Thomson SA; Kurilla MG; Moss DJ
Virology; 1995 Dec; 214(2):633-7. PubMed ID: 8553567
[TBL] [Abstract][Full Text] [Related]
35. An in vitro-transcribed-mRNA polyepitope construct encoding 32 distinct HLA class I-restricted epitopes from CMV, EBV, and Influenza for use as a functional control in human immune monitoring studies.
Nielsen JS; Wick DA; Tran E; Nelson BH; Webb JR
J Immunol Methods; 2010 Aug; 360(1-2):149-56. PubMed ID: 20637775
[TBL] [Abstract][Full Text] [Related]
36. G-quadruplexes regulate Epstein-Barr virus-encoded nuclear antigen 1 mRNA translation.
Murat P; Zhong J; Lekieffre L; Cowieson NP; Clancy JL; Preiss T; Balasubramanian S; Khanna R; Tellam J
Nat Chem Biol; 2014 May; 10(5):358-64. PubMed ID: 24633353
[TBL] [Abstract][Full Text] [Related]
37. Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing.
Blake N; Lee S; Redchenko I; Thomas W; Steven N; Leese A; Steigerwald-Mullen P; Kurilla MG; Frappier L; Rickinson A
Immunity; 1997 Dec; 7(6):791-802. PubMed ID: 9430224
[TBL] [Abstract][Full Text] [Related]
38. Effects of messenger RNA structure and other translational control mechanisms on major histocompatibility complex-I mediated antigen presentation.
Murat P; Tellam J
Wiley Interdiscip Rev RNA; 2015; 6(2):157-71. PubMed ID: 25264139
[TBL] [Abstract][Full Text] [Related]
39. PI3Kδ activates E2F1 synthesis in response to mRNA translation stress.
Gnanasundram SV; Pyndiah S; Daskalogianni C; Armfield K; Nylander K; Wilson JB; Fåhraeus R
Nat Commun; 2017 Dec; 8(1):2103. PubMed ID: 29235459
[TBL] [Abstract][Full Text] [Related]
40. Influenza A virus infection-induced macroautophagy facilitates MHC class II-restricted endogenous presentation of an immunodominant viral epitope.
Deng J; Lu C; Liu C; Oveissi S; Fairlie WD; Lee EF; Bilsel P; Puthalakath H; Chen W
FEBS J; 2021 May; 288(10):3164-3185. PubMed ID: 33830641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
